CCM2 exon 2-10 deletion research, led by Alliance to Cure Cavernous Malformation families and Duke University, has identified a new founder mutation. Read coverage in the Atlantic magazine.

The collaborative work done by families affected by the CCM2 exon 2-10 deletion, a very specific form of the illness, is bringing CCM visibility and understanding to a whole new level. This is what patients (and patient organizations) can do.

If your genetic testing indicates that your family is affected by the CCM2 exon 2-10 deletion and you’d like to participate in genealogy research, please contact Connie Lee at